Pre-close Trading Statement
Kromek Group expects to report revenue for H1 2026 of at least £14.5m, a significant increase from the £3.7m reported in H1 2025. This includes at least £8.2m in revenue from the Siemens Healthineers enablement agreement, compared to £nil in H1 2024. Underlying revenue is expected to be at least £6.3m, representing a 70% increase from the £3.7m in H1 2025, driven by growth in the CBRN Detection division and increased underlying revenue in Advanced Imaging. The company anticipates reporting profit before tax and positive adjusted EBITDA for H1 2026, a substantial improvement from the £5.7m loss before tax and £2.3m adjusted EBITDA loss in H1 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your KMK notes
Kromek (AIM: KMK), a global detection company delivering best-in-class solutions for the advanced imaging and CBRN detection markets, provides the following update on trading for the six months ending 31 October 2025 ("H1 2026").
The Group expects to report revenue for H1 2026 of at least £14.5m (H1 2025: £3.7m). This includes revenue generated under the Group's enablement agreement with Siemens Healthineers, as announced on 30 January 2025, of at least £8.2m (H1 2024: £nil). Accordingly, on an underlying basis, the Group expects to report revenue of at least £6.3m (H1 2025: £3.7m), representing growth of 70% over the first half of 2025. This was driven by strong growth in the CBRN Detection division as well as an increase in underlying revenue in the Advanced Imaging division.
As a result of the increase in revenue, along with an expected improvement in gross margin due to the contribution from Siemens Healthineers, the Group expects to report profit before tax and positive adjusted EBITDA for the first half of 2026 compared with a loss before tax of £5.7m and an adjusted EBITDA loss of £2.3m for H1 2025.
The Group's trading for the first half of the year reinforces the Board's confidence that the Group will deliver revenue growth for FY 2026 with results in line with market expectations
Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.